Guardant Health
GH
#1740
Rank
S$14.85 B
Marketcap
S$113.24
Share price
1.76%
Change (1 day)
84.18%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -S$0.55 Billion

According to Guardant Health 's latest financial reports the company's current earnings are S$0.98 Billion. , an increase over its 2024 earnings that were of -S$0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -S$0.54 Billion-4.03%
2024 -S$0.56 Billion-9.12%
2023 -S$0.62 Billion-26.73%
2022 -S$0.84 Billion69.96%
2021 -S$0.5 Billion56.35%
2020 -S$0.32 Billion252.69%
2019 -S$89.62 Million-17.22%
2018 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-S$0.8 Billion 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-S$0.35 Billion-35.79%๐Ÿ‡บ๐Ÿ‡ธ USA